55 results
S-3ASR
EX-4.3
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
such predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment
S-3ASR
EX-4.2
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
assessment or penalty or otherwise; it being expressly understood that this Indenture and the obligations issued hereunder are solely corporate obligations
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
committee retains an independent compensation consultant to provide support in its review and assessment of our executive compensation program … compensation peer group;
the performance of each individual executive officer, based on an assessment of his or her contributions to our overall
424B5
41kp5xejkv6 vyr
6 Mar 24
Prospectus supplement for primary offering
5:16pm
424B5
j4o5bcb
4 Mar 24
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
vn33ni6vu5i57bzrbmvq
29 Feb 24
Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:15am
8-K
EX-99.2
llmmtp0uanm8kci76
5 Jun 23
Results of Operations and Financial Condition
8:05am
424B5
53pp1j
17 May 23
Prospectus supplement for primary offering
4:45pm
424B5
tyr 9d7dgm
15 Sep 22
Prospectus supplement for primary offering
5:16pm
424B5
6h986f51i5
13 Sep 22
Prospectus supplement for primary offering
5:11pm